These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Terlipressin versus other vasoactive drugs for hepatorenal syndrome. Israelsen M; Krag A; Allegretti AS; Jovani M; Goldin AH; Winter RW; Gluud LL Cochrane Database Syst Rev; 2017 Sep; 9(9):CD011532. PubMed ID: 28953318 [TBL] [Abstract][Full Text] [Related]
13. Transjugular intrahepatic portosystemic shunts for adults with hepatorenal syndrome. Gonzalez-Garay AG; Serralde-Zúñiga AE; Velasco Hidalgo L; Flores García NC; Aguirre-Salgado MI Cochrane Database Syst Rev; 2024 Jan; 1(1):CD011039. PubMed ID: 38235907 [TBL] [Abstract][Full Text] [Related]
14. Gene therapy for people with hepatocellular carcinoma. Naing C; Ni H; Aung HH; Htet NH; Nikolova D Cochrane Database Syst Rev; 2024 Jun; 6(6):CD013731. PubMed ID: 38837373 [TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy of pharmacological strategies for management of type 1 hepatorenal syndrome: a systematic review and network meta-analysis. Facciorusso A; Chandar AK; Murad MH; Prokop LJ; Muscatiello N; Kamath PS; Singh S Lancet Gastroenterol Hepatol; 2017 Feb; 2(2):94-102. PubMed ID: 28403995 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological interventions for alcoholic liver disease (alcohol-related liver disease): an attempted network meta-analysis. Buzzetti E; Kalafateli M; Thorburn D; Davidson BR; Thiele M; Gluud LL; Del Giovane C; Askgaard G; Krag A; Tsochatzis E; Gurusamy KS Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011646. PubMed ID: 28368093 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological interventions for non-alcohol related fatty liver disease (NAFLD): an attempted network meta-analysis. Lombardi R; Onali S; Thorburn D; Davidson BR; Gurusamy KS; Tsochatzis E Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011640. PubMed ID: 28358980 [TBL] [Abstract][Full Text] [Related]
18. Terlipressin versus placebo or no intervention for people with cirrhosis and hepatorenal syndrome. Allegretti AS; Israelsen M; Krag A; Jovani M; Goldin AH; Schulman AR; Winter RW; Gluud LL Cochrane Database Syst Rev; 2017 Jun; 6(6):CD005162. PubMed ID: 29943803 [TBL] [Abstract][Full Text] [Related]